SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Ionis Confident It Can Compete With Alnylam

PHARMA: Cos. Clash as They Target Same Illness

Illumina Revenue Jumps 18 Percent in Q3

San Diego biotech Illumina reported that its Q3 revenue climbed 18 percent year over year.

Neurocrine Biosciences Gets New CFO

Matt Abernethy has been tapped as CFO of Neurocrine Biosciences.

Ionis Licenses Second Antisense Drug

Ionis Pharmaceuticals has licensed another antisense drug to Janssen Biotech.

Odonate Therapeutics Files for $173 M IPO

San Diego-based Odonate Therapeutics has filed with the SEC to raise up to $173 million in an IPO.

Thermo Fisher Awarded $40 Million Army Contract

The U.S. Army awarded Thermo Fisher Scientific Inc. a five-year, $40 million contract for customized reagents and consumables.

Tax Reform May Threaten Incentives for Orphan Drug Research

PHARMA: Sector Lobbies Against Changes; Cut Said to Bring $54B Over 10 Years

Drugmakers researching medicines for rare diseases could lose all or part of a tax credit under Republican tax overhaul proposals unveiled this month, sparking concern among San Diego’s biotech industry.

Tease photo

Arcturus Completes Merger with Alcobra, Lists on Nasdaq

San Diego’s Arcturus Therapeutics is now on the public markets following a merger with Alcobra, previously based in Israel.

Palomar Health to Build New Crisis Stabilization Unit

A standalone crisis stabilization unit will be built on the Palomar Medical Center Escondido campus.

UC San Diego Forms Medical Records Partnership

UC San Diego and UC Irvine Health are now on an integrated electronic medical records platform.

Tear Film Innovations Raises $9M in Financing Round

San Diego-based Tear Film Innovations Inc. said it has raised $9 million in a Series A preferred stock round.

Heron Therapeutics Wins FDA Approval for Chemotherapy Drug

The FDA has approved Heron Therapeutic's Cinvanti, an injectable drug for the prevention of chemotherapy-induced nausea and vomiting.

Palomar Health CEO Retires

Robert Hemker has announced his retirement as president and CEO of Palomar Health.

Hospitals See Harm in Insurer’s Imaging Policy Change

MEDICINE: Use of Centers Expected to Cut Costs

Anthem will no longer pay for outpatient MRIs and CT scans at hospitals, a decision that at least two San Diego hospital systems fear could chip away at care — and their bottom lines.

Tease photo

S.D. Coordinates Efforts to Put Hospital Stay on Tourist Itinerary

ECONOMY: Campaign Touts Region’s Prowess To Drive Medical Visits

For visitors, San Diego offers much more than beaches, craft beer and convention space.

Tease photo

Prev